Mena FN9d
IMCAS 2025: Galderma's Broad Presence And New Data On Recently Launched Products Restylane® SHAYPETM And Relfydess® Reaff...
New pooled data from three Galderma studies of the Restylane portfolio will be presented, demonstrating that treatments with Restylane RefyneTM and Restylane DefyneTM not only enhance ...
Forbes5mon
Why L’Oréal Dermatological Beauty Is Gaining Traction And Luxury Isn’t
L’Oréal just announced it acquired a 10% stake in Galderma, characterized as a “pure play dermatology leader” in injectibles with Botox-competitor Dysport, and Restylane filler brands.
Mena FN18d
Galderma Premieres Positive Interim Results Demonstrating The Efficacy Of Its Injectable Aesthetics Portfolio In Address...
(BUSINESS WIRE )--Galderma (SWX:GALD) announces positive first results from a trial designed to explore the benefits of Restylane® LyftTM or ContourTM in combination with Sculptra® in patients ...